Arrow Financial Corp Biogen Inc. Transaction History

Arrow Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 28, 2019	SELL	$217.44 - $243.88 $2,174 - $2,438	-10 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$219.29 - $241.72 $217,097 - $239,302	-990 Reduced 99.0%	10 $2,000
Q1 2019 Apr 26, 2019	BUY	$216.71 - $338.96 $216,710 - $338,960	1,000 New	1,000 $236,000
Q4 2018 Feb 04, 2019	SELL	$278.5 - $352.75 $296,602 - $375,678	-1,065 Closed	0 $0
Q3 2018 Oct 11, 2018	BUY	$293.51 - $383.83 $293,510 - $383,830	1,000 Added 1538.46%	1,065 $376,000
Q1 2018 Apr 25, 2018	SELL	$260.13 - $367.91 $1.3 Million - $1.84 Million	-5,000 Reduced 98.72%	65 $18,000
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $1.42 Million - $1.67 Million	5,065	5,065 $1.59 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Arrow Financial Corp with notifications on news.